Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers
Kris C. Wood(Duke University), Dylan J. Taatjes(University of Colorado Boulder), Christian Cerda-Smith(Duke University), Andrew M. Waters(University of North Carolina at Chapel Hill), Shannon J. McCall(Duke Medical Center), Amy Stewart(University of North Carolina at Chapel Hill), David Kantrowitz(University of North Carolina at Chapel Hill), Alejandro Barrera(Duke University), J. Joshua Smith(Memorial Sloan Kettering Cancer Center), Channing J. Der(University of North Carolina at Chapel Hill), Mariaelena Pierobon(George Mason University), Merve Çakır(University of California, San Francisco), Chao Wu(Memorial Sloan Kettering Cancer Center), Justine C. Rutter(Duke University), Colin A. Martz(Duke University), Daniel P. Nussbaum(Memorial Sloan Kettering Cancer Center), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Cecilia B. Levandowski(University of Colorado Boulder)
Cited by 0
Related Papers
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
|Cell|2020|1.1k
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
|Hepatology|2007|1k
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
|Science|2020|813
Pol II phosphorylation regulates a switch between transcriptional and splicing condensates
|Nature|2019|725
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717